Bioequivalence and Bioavailability Forum

Dear all,

yesterday EMA published two drafts:

• Guideline on quality of oral modified release products
  
• Guideline on quality of transdermal patches

These guidelines will replace the Note for Guidance on Modified Release Products (A: Oral Dosage Forms, B: Transdermal Dosage Forms). Part I (Quality).
Consultation started today and will end on 15 March 2013.